Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 275, Issue 9, Pages 6123-6128Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.275.9.6123
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL64793, HL61371, HL57665] Funding Source: Medline
Ask authors/readers for more resources
Bovine endothelial nitric oxide synthase (eNOS) is phosphorylated directly by the protein kinase Akt at serine 1179. Mutation of this residue to the negatively charged aspartate (S1179D eNOS) increases nitric oxide (NO) production constitutively, in the absence of agonist challenge. Here, me examine the potential mechanism of how aspartate at 1179 increases eNOS activity using purified proteins. Examination of NO production and cytochrome c reduction resulted in no substantial changes in the K-m/EC50 for L-arginine, calmodulin, and calcium, whereas there was a a-fold increase in the rate of NO production for S1179D and a 2-4 fold increase in reductase activity (based on cytochrome c reduction). The observed increase in activity for both assays of NOS function indicates that a faster rate of electron flux through the reductase domain is likely the rate-limiting step in NO formation from eNOS, In addition, S1179D eNOS did show an increased resistance to inactivation by EGTA compared with mild type eNOS. These results suggest that a negative charge imposed at serine 1179, either by phosphorylation or by replacement with aspartate, increases eNOS catalytic activity by increasing electron flux at the reductase domain and by reducing calmodulin dissociation from activated eNOS when calcium levels are low.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available